ENHANCED ANTIPLATELET THERAPY IS MORE IMPORTANT THAN CHOICE OF THROMBOLYTIC AGENT IN THE TREATMENT OF MYOCARDIAL-INFARCTION

Authors
KRUCOFF MW GREEN CL TROLLINGER KM MAAS A MOLITERNO DJ HARRINGTON RA OCONNOR CM POPE JE
Citation
Mw. Krucoff et al., ENHANCED ANTIPLATELET THERAPY IS MORE IMPORTANT THAN CHOICE OF THROMBOLYTIC AGENT IN THE TREATMENT OF MYOCARDIAL-INFARCTION, Circulation, 96(8), 1997, pp. 2647-2647
Citations number
NO
Categorie Soggetti
Peripheal Vascular Diseas",Hematology
Journal title
Circulation → ACNP
ISSN journal
00097322
Volume
96
Issue
8
Year of publication
1997
Supplement
S
Pages
2647 - 2647
Database
ISI
SICI code
0009-7322(1997)96:8<2647:EATIMI>2.0.ZU;2-W